John Crown

38.4k citations
418 papers · 20.4k · 4 hit papers · h-index 71

Impact in

  • Oncology top 0.05%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways
    • Cancer Immunotherapy and Biomarkers
    • Breast Cancer Treatment Studies
    • MicroRNA in disease regulation

Papers in

    • HER2/EGFR in Cancer Research 133
    • Cancer Treatment and Pharmacology 98
    • Cancer-related Molecular Pathways 24
    • Advanced Breast Cancer Therapies 65
    • Lung Cancer Treatments and Mutations 39

John Crown

409 papers receiving 20.0k citations

John Crown's Hit Papers

MYC as a target for cancer treatment 2021 · 319 citations
3190+6+13Years since publication50010001.5k2.0k2.5k

Peers

John Crown
Comparison fields: 5 of 156
  • Oncology 10.6k
  • Cancer Research 4.8k
  • Pulmonary and Respiratory Medicine 3.9k
  • Molecular Biology 6.5k
  • Genetics 864
Replace George W. Sledge with:
George W. Sledge United States
Masakazu Toi Japan
Karen A. Gelmon Canada
Giampaolo Tortora Italy
Jennifer R. Grandis United States
Emile E. Voest Netherlands
Sandra M. Swain United States
Manuel Hidalgo United States
Brian Leyland‐Jones United States
Beverly A. Teicher United States
John Crown relative to George W. Sledge United States George W. Sledge's profile →
Citations per field
00.5×1.5×
George W. Sledge · 1×
Citations per year

Countries citing papers authored by John Crown

Since Specialization
Citations

This map shows the geographic impact of John Crown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Crown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Crown more than expected).

Fields of papers citing papers by John Crown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Crown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Crown. The network helps show where John Crown may publish in the future.

Co-authors

The 25 scholars most cited alongside John Crown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Crown Line = papers co-authored together John Crown links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 418 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Hit paper breakdown →
20062514
2
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Hit paper breakdown →
20141435
3
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
Hit paper breakdown →
20131231
4 2012383
5
MYC as a target for cancer treatment
Hit paper breakdown →
2021319
6 2000303
7 2013297
8 2019288
9 2017285
10 2009282
11 2020253
12 2010249
13 2014239
14 1993207
15 2004202
16 2004201
17 2013191
18 2014182
19 2019180
20 1995179

About John Crown

John Crown is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 418 papers that have together received 20.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (133 papers), Cancer Treatment and Pharmacology (98 papers), Breast Cancer Treatment Studies (69 papers), Advanced Breast Cancer Therapies (65 papers), Lung Cancer Treatments and Mutations (39 papers), Monoclonal and Polyclonal Antibodies Research (31 papers), Cancer Genomics and Diagnostics (28 papers) and Cancer-related Molecular Pathways (24 papers). The work is most often cited by research in Oncology (10.6k citations), Cancer Research (4.8k citations), Pulmonary and Respiratory Medicine (3.9k citations), Molecular Biology (6.5k citations) and Genetics (864 citations). John Crown has collaborated with scholars based in Ireland, United States and Germany. Frequent co-authors include Michael J. Duffy, Norma O’Donovan, Naoise C. Synnott, Martin Clynes, Lorraine O’Driscoll, Michael P. O’Leary, Tadeusz Pieńkowski, Dennis J. Slamon, Patricia M. McGowan and Shane O’Grady. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Breast Cancer Research and Treatment and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact